These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 10102455)

  • 1. The clearance of thrombin-antithrombin and related serpin-enzyme complexes from the circulation: role of various hepatocyte receptors.
    Wells MJ; Sheffield WP; Blajchman MA
    Thromb Haemost; 1999 Mar; 81(3):325-37. PubMed ID: 10102455
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibitory mechanism of serpins. Interaction of thrombin with antithrombin and protease nexin 1.
    Stone SR; Hermans JM
    Biochemistry; 1995 Apr; 34(15):5164-72. PubMed ID: 7711036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protease nexin-1: a regulator of vascular disease?
    Ferroni P; Guadagni F
    J Thromb Haemost; 2006 Feb; 4(2):320-1. PubMed ID: 16420558
    [No Abstract]   [Full Text] [Related]  

  • 4. Serpin receptor 1: a hepatic receptor that mediates the clearance of antithrombin III-proteinase complexes.
    Pizzo SV
    Am J Med; 1989 Sep; 87(3B):10S-14S. PubMed ID: 2552799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of Cellular Uptake of Thrombin-Antithrombin II Complexes Role of the Low-Density Lipoprotein Receptor-Related Protein as a Serpin-Enzyme Complex Receptor.
    Strickland DK; Kounnas MZ
    Trends Cardiovasc Med; 1997 Jan; 7(1):9-16. PubMed ID: 21235858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein disulfide isomerase catalyzes the formation of disulfide-linked complexes of vitronectin with thrombin-antithrombin.
    Essex DW; Miller A; Swiatkowska M; Feinman RD
    Biochemistry; 1999 Aug; 38(32):10398-405. PubMed ID: 10441134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the in vivo clearance of thrombin.
    Gans H; Stern R; Tan BH
    Thromb Diath Haemorrh; 1969 Aug; 22(1):1-12. PubMed ID: 5821242
    [No Abstract]   [Full Text] [Related]  

  • 8. RNA aptamer to thrombin binds anion-binding exosite-2 and alters protease inhibition by heparin-binding serpins.
    Jeter ML; Ly LV; Fortenberry YM; Whinna HC; White RR; Rusconi CP; Sullenger BA; Church FC
    FEBS Lett; 2004 Jun; 568(1-3):10-4. PubMed ID: 15196911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proceedings: The effect of divalent cations on the interaction between thrombin and antithrombin.
    Osamo NO
    Thromb Diath Haemorrh; 1975 Sep; 34(1):347. PubMed ID: 1188793
    [No Abstract]   [Full Text] [Related]  

  • 10. Intracellular retention of hepatic serpins caused by severe hyperlipidemia.
    Hernández-Espinosa D; Ayala I; Castells MT; García-Pérez B; Martín-Castillo A; Miñano A; Arcas I; Vicente V; Corral J
    Liver Int; 2006 Aug; 26(6):708-15. PubMed ID: 16842328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surface plasmon resonance spectroscopy study of interfacial binding of thrombin to antithrombin DNA aptamers.
    Tang Q; Su X; Loh KP
    J Colloid Interface Sci; 2007 Nov; 315(1):99-106. PubMed ID: 17689549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of complement S-protein with thrombin-antithrombin complexes: a role for the S-protein in haemostasis.
    Jenne D; Hugo F; Bhakdi S
    Thromb Res; 1985 May; 38(4):401-12. PubMed ID: 2409614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low levels of vitronectin and clusterin in acute meningococcal disease are closely associated with formation of the terminal-complement complex and the vitronectin-thrombin-antithrombin complex.
    Høgåsen K; Mollnes TE; Brandtzaeg P
    Infect Immun; 1994 Nov; 62(11):4874-80. PubMed ID: 7523299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of the coagulation system by serpins. Getting by with a little help from glycosaminoglycans.
    Pike RN; Buckle AM; le Bonniec BF; Church FC
    FEBS J; 2005 Oct; 272(19):4842-51. PubMed ID: 16176258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitronectin inhibits plasminogen activator inhibitor-1-induced signalling and chemotaxis by blocking plasminogen activator inhibitor-1 binding to the low-density lipoprotein receptor-related protein.
    Kamikubo Y; Neels JG; Degryse B
    Int J Biochem Cell Biol; 2009 Mar; 41(3):578-85. PubMed ID: 18703159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The site in human antithrombin for functional proteolytic cleavage by human thrombin.
    Björk I; Danielsson A; Fenton JW; Jörnvall
    FEBS Lett; 1981 Apr; 126(2):257-60. PubMed ID: 7238875
    [No Abstract]   [Full Text] [Related]  

  • 17. GPV is a marker of in vivo platelet activation--study in a rat thrombosis model.
    Ravanat C; Freund M; Mangin P; Azorsa DO; Schwartz C; Moog S; Schuhler S; Dambach J; Cazenave JP; Lanza F
    Thromb Haemost; 2000 Feb; 83(2):327-33. PubMed ID: 10739394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Slow, spontaneous dissociation of the antithrombin-thrombin complex produces a proteolytically modified form of the inhibitor.
    Danielsson A; Björk I
    FEBS Lett; 1980 Oct; 119(2):241-4. PubMed ID: 7428936
    [No Abstract]   [Full Text] [Related]  

  • 19. Latent and polymeric antithrombin: clearance and potential thrombotic risk.
    Corral J; Rivera J; Guerrero JA; Miñano A; Alberca I; Hernández-Espinosa D; Ordóñez A; Martínez C; Navarro-Núñez L; González-Conejero R; Lozano ML; Vicente V
    Exp Biol Med (Maywood); 2007 Feb; 232(2):219-26. PubMed ID: 17259329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycosaminoglycans and the regulation of blood coagulation.
    Bourin MC; Lindahl U
    Biochem J; 1993 Jan; 289 ( Pt 2)(Pt 2):313-30. PubMed ID: 8380990
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.